The PI3K/mTOR inhibitor NVP-BEZ235 selectively killed MYCN-expressing neuroblastoma tumor cells through apoptosis and concomitantly eliminated MYCN protein in vivo [140]. The gene discussed is MYCN; the disease is neuroblastoma.